Simplex Trading’s Immune Design IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-273
Closed -$94K – 8547
2018
Q3
$94K Sell
273
-120
-31% -$451 ﹤0.01% 4502
2018
Q2
$178K Buy
+393
New +$1.57K ﹤0.01% 3634
2017
Q4
– Sell
-70
Closed -$11K – 7348
2017
Q3
$11K Buy
+70
New +$689 ﹤0.01% 3745
2017
Q2
– Sell
-20
Closed -$5K – 7458
2017
Q1
$5K Buy
+20
New +$116 ﹤0.01% 4706

Simplex Trading's IMDZ Position: Q2 2019 in Review

Simplex Trading sold out of Immune Design (IMDZ) in Q2 2019, closing a stake of 2,400 shares — an estimated $14K sold.

Simplex Trading first reported a position in IMDZ in Q4 2017 and held it in 3 quarters. The position peaked at $38K in Q4 2017. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • Simplex Trading reported no remaining Immune Design position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 2,400 Immune Design shares in Q2 2019, an estimated $14K.
  • Simplex Trading first reported a position in Immune Design in Q4 2017 and held it in 3 quarters.
  • Simplex Trading's Immune Design position peaked at $38K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Immune Design as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.